Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gail F Schwartz

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
American Journal of Ophthalmology|December 31, 2003
Persistency and tolerability of ocular hypotensive agents: population-based evidence in the management of glaucomaGail F Schwartz
Current Opinion in Ophthalmology|March 4, 2005
Compliance and persistency in glaucoma follow-up treatmentGail F Schwartz
Survey of Ophthalmology|November 9, 2004
A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertensionGail F Schwartz, Gregory Reardon
The American Journal of Managed Care|August 22, 2002
Measuring persistency and intraocular pressure-controlled days in patients receiving topical glaucoma medicationsGail F Schwartz, Robert Platt
Survey of Ophthalmology|December 17, 2008
Adherence and persistence with glaucoma therapyGail F Schwartz, Harry A Quigley
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|December 24, 2009
Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogsGail F Schwartz, Jason Tan, Sameer Kotak
American Journal of Ophthalmology|December 31, 2003
Persistency with latanoprost or timolol in primary open-angle glaucoma suspectsGail F Schwartz, Gregory Reardon, Essy Mozaffari
Patient Preference and Adherence|October 18, 2011
Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic reviewGregory Reardon, Sameer Kotak, Gail F Schwartz
American Journal of Ophthalmology|December 31, 2003
Patient persistency with topical ocular hypotensive therapy in a managed care populationGregory Reardon, Gail F Schwartz, Essy Mozaffari
Clinical Therapeutics|June 18, 2003
Patient persistency with ocular prostaglandin therapy: a population-based, retrospective studyGregory Reardon, Gail F Schwartz, Essy Mozaffari
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
American Journal of Ophthalmology|December 31, 2003
Persistency and tolerability of ocular hypotensive agents: population-based evidence in the management of glaucomaGail F Schwartz
Current Opinion in Ophthalmology|March 4, 2005
Compliance and persistency in glaucoma follow-up treatmentGail F Schwartz
Survey of Ophthalmology|November 9, 2004
A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertensionGail F Schwartz, Gregory Reardon
The American Journal of Managed Care|August 22, 2002
Measuring persistency and intraocular pressure-controlled days in patients receiving topical glaucoma medicationsGail F Schwartz, Robert Platt
Survey of Ophthalmology|December 17, 2008
Adherence and persistence with glaucoma therapyGail F Schwartz, Harry A Quigley
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|December 24, 2009
Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogsGail F Schwartz, Jason Tan, Sameer Kotak
American Journal of Ophthalmology|December 31, 2003
Persistency with latanoprost or timolol in primary open-angle glaucoma suspectsGail F Schwartz, Gregory Reardon, Essy Mozaffari
Patient Preference and Adherence|October 18, 2011
Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic reviewGregory Reardon, Sameer Kotak, Gail F Schwartz
American Journal of Ophthalmology|December 31, 2003
Patient persistency with topical ocular hypotensive therapy in a managed care populationGregory Reardon, Gail F Schwartz, Essy Mozaffari
Clinical Therapeutics|June 18, 2003
Patient persistency with ocular prostaglandin therapy: a population-based, retrospective studyGregory Reardon, Gail F Schwartz, Essy Mozaffari
Pageof 3